Yuichi Wakabayashi

With 3,000+ stem cell cases personally managed across approximately 20 countries, Dr. Yuichi Wakabayashi leads regenerative medicine at the clinic in Osaka with an unusually hands-on workflow. The international process is structured to start before travel: patients submit medical history via email or WhatsApp, then Dr. Wakabayashi personally reviews eligibility and expected protocol before a written reply is sent. He can communicate directly with international patients in English, and the clinic describes ongoing remote follow-up by WhatsApp or email after in-person visits. At the clinic, the treatment pathway is built around a staged timeline. On the first Osaka visit (1 day), patients undergo blood tests and a mini adipose tissue harvesting under local anesthesia (about 30 minutes). Stem cell cultivation then takes about 7 weeks at the clinic’s certified Cell Processing Center (CPC), where cells are expanded to 100–200 million and tested for viability (98%+ mentioned), with infectious-agent screening and a certificate of quality. The second Osaka visit (1 day) includes cultured stem cell infusion via IV or targeted injection, followed by remote follow-up at set intervals.

Education

• Kobe University — M.D. (year not stated in the clinic materials).
• Kobe University — Ph.D. (year not stated in the clinic materials).
• U.S. National Institutes of Health (NIH) — research training in neurological disorders (years not stated).

Work experience

• Cell Grand Clinic, Osaka — Medical Director (start year not stated; current role mentioned).
• U.S. National Institutes of Health (NIH) — research experience in neurological disorders (role described; years not stated).

Clinical focus and techniques

Dr. Wakabayashi’s clinical work centers on regenerative medicine for chronic conditions and longevity-related goals, using autologous, lab-cultivated cell products and targeted administration routes.

• Mini adipose tissue harvesting under local anesthesia (about 30 minutes) for stem cell therapy.
• Stem cell cultivation/expansion to 100–200 million cells at a certified CPC over ~7 weeks.
• Cultured stem cell infusion via IV.
• Targeted injection of cultured stem cells.
• Intra-articular injection for knee osteoarthritis (stem cell therapy).
• Exosome IV infusion and exosome facial treatments.
• NMN IV drip.
• PRP (platelet-rich plasma) intra-articular injection therapy.

Professional societies and certifications

• American Board of Regenerative Medicine (ABRM) — Diplomate (certification stated).
• Harvard Medical School — Certificate in Stem Cell Medicine (CME) (certificate stated).
• Japan Society of Anti-Aging Medicine — Board-Certified Specialist (certificate stated).
• Japanese Society for Regenerative Medicine — Member (membership stated).
• Japan Society for Dementia Research — Member (membership stated).

Academic output

The clinic materials state that Dr. Wakabayashi has authored 6 peer-reviewed English-language publications.

Courses and advanced training

Awards and recognition

• 2026 Healthcare Business Review APAC — Top Regenerative Medicine Solution in APAC (awardee; year stated as 2026).
• Medical Excellence JAPAN — member clinic (Cell Grand Clinic is described as a Medical Excellence JAPAN member clinic; year not stated).

International patients are supported in English, Japanese, and Mandarin Chinese, and the clinic describes responses under 24 hours Japan time. Care is delivered in Osaka, with remote consultation before travel and ongoing remote follow-up via WhatsApp or email. The clinic’s stated approach emphasizes that eligibility, dosing expectations, and the treatment timeline are assessed personally by Dr. Wakabayashi rather than by a sales coordinator.